申请人:Proximagen Limited
公开号:US10065954B2
公开(公告)日:2018-09-04
Specific compounds of formula (Ia):
and pharmaceutically acceptable salts thereof. Pharmaceutical compositions of the specific compounds of formula (Ia) and pharmaceutically acceptable salts thereof. A method for inhibiting tumor growth in a subject that includes administering to the subject an effective amount of a compound selected from the specific compounds of formula (Ia) and pharmaceutically acceptable salts thereof. A method for modulating semicarbazide-sensitive amine oxidase activity in a subject that includes administering to the subject an effective amount of a compound selected from the specific compounds of formula (Ia) and pharmaceutically acceptable salts thereof.
式 (Ia) 的特定化合物:
及其药学上可接受的盐类。式(Ia)的特定化合物及其药学上可接受的盐的药物组合物。一种抑制受试者肿瘤生长的方法,包括向受试者施用有效量的选自式(Ia)特定化合物及其药学上可接受的盐的化合物。一种调节受试者体内对氨基脲敏感的胺氧化酶活性的方法,包括向受试者施用有效量的选自式(Ia)特定化合物及其药学上可接受的盐的化合物。